| Ryan Abbaszadeh, | |
|
4700 Waters Ave Ste 403, Savannah, GA 31404-6220 | |
| (912) 273-1150 | |
| Not Available |
| Full Name | Ryan Abbaszadeh |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 10 Years |
| Location | 4700 Waters Ave Ste 403, Savannah, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730508714 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 89235 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial University Medical Center | Savannah, GA | Hospital |
| East Georgia Regional Medical Center | Statesboro, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Savannah Multispecialty Associates Llc | 3678836558 | 112 |
News Archive
University of Cincinnati (UC) cancer and cell biologists have identified a new molecular pathway key to the development of invasive prostate cancers.
Patients who develop Type 2 diabetes before the age of 40 years have higher complication risks at any given age than those who develop it later in life, research shows.
New research confirms that the lower 0.25 mg/kg dose of the clot-busting agent tenecteplase is appropriate for eligible stroke patients and can reduce the need for mechanical clot removal, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.
Miami resident Ingrid Mazorra pleaded guilty today in U.S. District Court in Miami to participating in a conspiracy to defraud the Medicare program, announced Assistant Attorney General Lanny A. Breuer of the Criminal Division; U.S. Attorney Terrence I. Berg of the Eastern District of Michigan; Andrew G. Arena, Special Agent-in-Charge of the FBI's Detroit Field Office; and Daniel R. Levinson, Inspector General of the Department of Health & Human Services (HHS).
Cerecor Inc., a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human nervous system, today announced that its Investigational New Drug (IND) Application for FP01 for the treatment of cough has cleared the 30 day deliberation period by the U.S. Food and Drug Administration.
› Verified 6 days ago
| Entity Name | Savannah Multispecialty Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528571320 PECOS PAC ID: 3678836558 Enrollment ID: O20180609000022 |
News Archive
University of Cincinnati (UC) cancer and cell biologists have identified a new molecular pathway key to the development of invasive prostate cancers.
Patients who develop Type 2 diabetes before the age of 40 years have higher complication risks at any given age than those who develop it later in life, research shows.
New research confirms that the lower 0.25 mg/kg dose of the clot-busting agent tenecteplase is appropriate for eligible stroke patients and can reduce the need for mechanical clot removal, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.
Miami resident Ingrid Mazorra pleaded guilty today in U.S. District Court in Miami to participating in a conspiracy to defraud the Medicare program, announced Assistant Attorney General Lanny A. Breuer of the Criminal Division; U.S. Attorney Terrence I. Berg of the Eastern District of Michigan; Andrew G. Arena, Special Agent-in-Charge of the FBI's Detroit Field Office; and Daniel R. Levinson, Inspector General of the Department of Health & Human Services (HHS).
Cerecor Inc., a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human nervous system, today announced that its Investigational New Drug (IND) Application for FP01 for the treatment of cough has cleared the 30 day deliberation period by the U.S. Food and Drug Administration.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Abbaszadeh, 4700 Waters Ave Ste 403, Savannah, GA 31404-6220 Ph: (912) 273-1150 | Ryan Abbaszadeh, 4700 Waters Ave Ste 403, Savannah, GA 31404-6220 Ph: (912) 273-1150 |
News Archive
University of Cincinnati (UC) cancer and cell biologists have identified a new molecular pathway key to the development of invasive prostate cancers.
Patients who develop Type 2 diabetes before the age of 40 years have higher complication risks at any given age than those who develop it later in life, research shows.
New research confirms that the lower 0.25 mg/kg dose of the clot-busting agent tenecteplase is appropriate for eligible stroke patients and can reduce the need for mechanical clot removal, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.
Miami resident Ingrid Mazorra pleaded guilty today in U.S. District Court in Miami to participating in a conspiracy to defraud the Medicare program, announced Assistant Attorney General Lanny A. Breuer of the Criminal Division; U.S. Attorney Terrence I. Berg of the Eastern District of Michigan; Andrew G. Arena, Special Agent-in-Charge of the FBI's Detroit Field Office; and Daniel R. Levinson, Inspector General of the Department of Health & Human Services (HHS).
Cerecor Inc., a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human nervous system, today announced that its Investigational New Drug (IND) Application for FP01 for the treatment of cough has cleared the 30 day deliberation period by the U.S. Food and Drug Administration.
› Verified 6 days ago
Dr. Chadwick William Stouffer, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 4700 Waters Ave Ste 400, Savannah, GA 31404 Phone: 912-273-1100 Fax: 912-273-1111 | |
Dr. Lourens J Willekes Ii, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 4700 Waters Ave Ste 400, Savannah, GA 31404 Phone: 912-273-1100 Fax: 912-273-1111 | |
David V Capallo, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 900 Mohawk Street Ste E, Savannah, GA 31419 Phone: 912-925-0067 Fax: 912-629-0280 | |
Brian Marcus Bailey, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 5354 Reynolds St Ste 102, Savannah, GA 31405 Phone: 912-819-0500 Fax: 912-819-0501 | |
Dariush Heidary, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 4750 Waters Ave, Suite 452, Savannah, GA 31404 Phone: 912-354-7188 Fax: 912-354-5208 | |
R Alan Hall, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 815 E 63rd St, Savannah, GA 31405 Phone: 912-355-8188 Fax: 912-356-6970 |